Advanced Search:
Equity Index

BOI.PA - BOIRON

€33.62  0.34 (1.02%)

Updated: 11:45 May 5, 2024 EST

Next Session's AI Forecast

99.34%

Avg. Accuracy (AI)

€34.18

Next Week's AI Forecast

0%

Trend's Accuracy (AI)

€33.02

BOIRON's Position Within the Drug Manufacturers - Specialty & Generic Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

BOIRON - HISTORICAL DATA 6M

  • Last price

    €33.62

  • Daily change

    €0.34

  • Previous Close

    €33.28

  • Last Updated

    11:45 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-0.15 -0.01 -0.09 -0.18 -0.06

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.26 0.78 1.17 1.2 1.34

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
13.33% 13.33% 27.78% 35.13%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
34.22 0.44% 34.07 0.29% 33.97 -10.11% 37.79

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.71 66.67 1.15 41.52

BOIRON Technical Analysis News

BOIRON

2, avenue de l’Ouest Lyonnais
Messimy 69510
France
33 4 78 45 61 00
https://www.boiron.fr

Sectors: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
F. Time Employees: 2813
Description

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Corporate Governance

Boiron SA’s ISS Governance QualityScore as of May 1, 2024 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder Rights: 6; Compensation: 9.

BOIRON'S HOLDERS RANK

List of holders with stock participation in BOIRON.

Holder Rank Holder Shares Date Reported % Out Value